KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Long-Term Investments (2016 - 2025)

Sarepta Therapeutics (SRPT) has 13 years of Long-Term Investments data on record, last reported at $195.5 million in Q2 2025.

  • For Q2 2025, Long-Term Investments changed N/A year-over-year to $195.5 million; the TTM value through Jun 2025 reached $195.5 million, changed N/A, while the annual FY2024 figure was $3.7 million, N/A changed from the prior year.
  • Long-Term Investments reached $195.5 million in Q2 2025 per SRPT's latest filing, up from $154.4 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $195.5 million in Q2 2025 and bottomed at $3.7 million in Q4 2024.
  • Average Long-Term Investments over 5 years is $66.3 million, with a median of $31.3 million recorded in 2022.
  • Peak YoY movement for Long-Term Investments: surged 317.84% in 2021, then crashed 53.72% in 2022.
  • A 5-year view of Long-Term Investments shows it stood at $34.9 million in 2021, then decreased by 10.23% to $31.3 million in 2022, then decreased by 1.02% to $31.0 million in 2023, then crashed by 88.03% to $3.7 million in 2024, then surged by 5170.13% to $195.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Long-Term Investments were $195.5 million in Q2 2025, $154.4 million in Q1 2025, and $3.7 million in Q4 2024.